SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness

SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, could offer protective immunity, and may affect clinical outcomes of COVID-19 patients. We analyzed 625 serial plasma samples...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:medRxiv
Main Authors: Röltgen, Katharina, Wirz, Oliver F., Stevens, Bryan A., Powell, Abigail E., Hogan, Catherine A., Najeeb, Javaria, Hunter, Molly, Sahoo, Malaya K., Huang, ChunHong, Yamamoto, Fumiko, Manalac, Justin, Otrelo-Cardoso, Ana R., Pham, Tho D., Rustagi, Arjun, Rogers, Angela J., Shah, Nigam H., Blish, Catherine A., Cochran, Jennifer R., Nadeau, Kari C., Jardetzky, Theodore S., Zehnder, James L., Wang, Taia T., Kim, Peter S., Gombar, Saurabh, Tibshirani, Robert, Pinsky, Benjamin A., Boyd, Scott D.
Formato: Artigo
Idioma:Inglês
Publicado em: Cold Spring Harbor Laboratory 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444305/
https://ncbi.nlm.nih.gov/pubmed/32839786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.15.20175794
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados